Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2021-07-15 00:00:00 ET · period of report 2021-07-15 · accession 0001179110-21-007506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-15 | 2021-07-15 | HALO | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $6.55 | +14.7K | 148.8K | +11% | +$96.2K |
| D | 2021-07-15 | 2021-07-15 | HALO | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $0.00 | -14.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-15 | M | A | 14,685 | $6.55 | 148,796 | D | — | — | |
| 2 | Derivative | Option to Purchase Common Stock | 2021-07-15 | M | D | 14,685 | $0.00 | 0 | D | $6.55 · — to 2023-02-04 | 14,685 Common Stock | (F1) This option was granted on February 4, 2013 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |